WHO grade 4 isocitrate dehydrogenase-wild type (IDH-WT) gliomas are also known as glioblastomas (GBMs) and generally have a median survival time of 12–15 months after diagnosis4. The gene discussed is IDH1; the disease is glioblastoma.